The gut microbiome, microbial metabolites, and cardiovascular disease in people living with HIV

BA Peters, RD Burk, RC Kaplan, Q Qi - Current HIV/AIDS Reports, 2023 - Springer
Abstract Purpose of Review To synthesize recent evidence relating the gut microbiome and
microbial metabolites to cardiovascular disease (CVD) in people living with HIV (PLWH) …

Non-HIV comorbid conditions and polypharmacy among people living with HIV age 65 or older compared with HIV-negative individuals age 65 or older in the United …

AM Kong, A Pozen, K Anastos, EA Kelvin… - AIDS patient care and …, 2019 - liebertpub.com
The number of people living with HIV (PLWH)≥ 65 years is increasing in the United States.
By 2035, the proportion of PLWH in this age group is projected to be 27%. As PLWH live …

Long-term persistence of transcriptionally active 'defective'HIV-1 proviruses: Implications for persistent immune activation during antiretroviral therapy

K Singh, V Natarajan, R Dewar, A Rupert, Y Badralmaa… - Aids, 2023 - journals.lww.com
Objectives: People with HIV-1 (PWH) on effective antiretroviral therapy (ART) continue to
exhibit chronic systemic inflammation, immune activation, and persistent elevations in …

The burden of non‐communicable diseases and mortality in people living with HIV (PLHIV) in the pre‐, early‐and late‐HAART era

NA Jespersen, F Axelsen, J Dollerup… - HIV …, 2021 - Wiley Online Library
Objectives To estimate the burden of non‐communicable diseases (NCDs) and mortality
among PLHIV in the pre‐, early‐and late‐HAART (highly active antiretroviral therapy) era …

Cohort profile: InfCareHIV, a prospective registry-based cohort study of people with diagnosed HIV in Sweden

C Carlander, J Brännström, F Månsson, O Elvstam… - BMJ open, 2023 - bmjopen.bmj.com
Purpose The Swedish InfCareHIV cohort was established in 2003 to ensure equal and
effective care of people living with HIV (PLHIV) and enable long-term follow-up. InfCareHIV …

Exploring caregiver experiences and support needs in end-of-life care for people living with HIV: A scoping review protocol

KM Kokorelias, AD Eaton, M Wasilewski, T Redublo… - Plos one, 2024 - journals.plos.org
Background and objectives End-of-life care supports individuals in the last few weeks or
months of their life and their caregivers, offering psychosocial support, symptom …

Factors Associated with Late Diagnosis of Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) in a University Hospital in Brazil …

LMN Arantes, AO Pedroso, MG Menegueti, E Gir… - Viruses, 2023 - mdpi.com
Introduction: This study aimed to identify factors associated with late diagnosis and clinically
monitor newly diagnosed HIV/AIDS patients. Method: Retrospective study, based on …

Mechanisms of systemic low-grade inflammation in HIV patients on long-term suppressive antiretroviral therapy: The inflammasome hypothesis

F Guerville, M Vialemaringe, C Cognet, P Duffau… - AIDS, 2023 - journals.lww.com
Objective: We aimed to determine the contribution of inflammasome activation in chronic low-
grade systemic inflammation observed in patients with HIV (PWH) on long-term suppressive …

The prevalence and risk of non-infectious comorbidities in HIV-infected and non-HIV infected men attending general practice in Australia

JE Heron, SM Norman, J Yoo, K Lembke… - PloS one, 2019 - journals.plos.org
Background Non-AIDS-related mortality rates among HIV-infected patients still exceed those
of their uninfected peers. A major driver of this excess mortality is a higher risk of non …

Associations between HIV viremia during antiretroviral therapy and cardiovascular disease

O Elvstam, G Marrone, G Engström, PM Nilsson… - AIDS, 2022 - journals.lww.com
Objective: To investigate the association between HIV viremia exposure during antiretroviral
therapy (ART) and cardiovascular disease (CVD) risk. Design: Nationwide observational …